| The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers L Mellish, EA Karanges, MJ Litchfield, AL Schaffer, B Blanch, BJ Daniels, ... BMC research notes 8, 1-13, 2015 | 277 | 2015 |
| Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis TA Couttas, N Kain, B Daniels, XY Lim, C Shepherd, J Kril, R Pickford, ... Acta neuropathologica communications 2, 1-13, 2014 | 176 | 2014 |
| A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis HJ Abuhusain, A Matin, Q Qiao, H Shen, N Kain, BW Day, BW Stringer, ... Journal of Biological Chemistry 288 (52), 37355-37364, 2013 | 153 | 2013 |
| Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling C Henry, A Quadir, NJ Hawkins, E Jary, E Llamosas, D Kumar, B Daniels, ... Journal of cancer research and clinical oncology 141, 243-254, 2015 | 80 | 2015 |
| Psychotropic medication use in Australia, 2007 to 2015: changes in annual incidence, prevalence and treatment exposure J Brett, EA Karanges, B Daniels, NA Buckley, C Schneider, A Nassir, ... Australian & New Zealand Journal of Psychiatry 51 (10), 990-999, 2017 | 76 | 2017 |
| Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016 B Daniels, SA Pearson, NA Buckley, C Bruno, H Zoega Therapeutic advances in gastroenterology 13, 1756284820913743, 2020 | 45 | 2020 |
| Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study J Brett, B Daniels, EA Karanges, NA Buckley, C Schneider, A Nassir, ... British journal of clinical pharmacology 83 (11), 2581-2588, 2017 | 39 | 2017 |
| Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study IA Bilmon, LJ Ashton, RE Le Marsney, AJ Dodds, TA O'brien, L Wilcox, ... Bone marrow transplantation 49 (5), 691-698, 2014 | 37 | 2014 |
| ROR1 and ROR2 play distinct and opposing roles in endometrial cancer CE Henry, E Llamosas, B Daniels, A Coopes, K Tang, CE Ford Gynecologic oncology 148 (3), 576-584, 2018 | 35 | 2018 |
| ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004–2014 R Cairns, B Daniels, DA Wood, J Brett Medical Journal of Australia 204 (4), 154-154, 2016 | 34 | 2016 |
| Second cancer risk and late mortality in adult Australians receiving allogeneic hematopoietic stem cell transplantation: a population-based cohort study CM Vajdic, E Mayson, AJ Dodds, T O'Brien, L Wilcox, I Nivison-Smith, ... Biology of Blood and Marrow Transplantation 22 (5), 949-956, 2016 | 30 | 2016 |
| Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population‐based case‐control study B Daniels, SA Pearson, CM Vajdic, A Pottegård, NA Buckley, H Zoega Basic & Clinical Pharmacology & Toxicology 127 (4), 320-328, 2020 | 29 | 2020 |
| Metastatic breast cancer incidence, site and survival in Australia, 2001–2016: a population-based health record linkage study protocol SJ Lord, BE Kiely, SA Pearson, B Daniels, DL O’Connell, J Beith, ... BMJ open 9 (2), e026414, 2019 | 26 | 2019 |
| Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian … B Daniels, BE Kiely, SJ Lord, N Houssami, CY Lu, RL Ward, SA Pearson Breast Cancer Research and Treatment 171, 151-159, 2018 | 26 | 2018 |
| Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001–2016) B Daniels, BE Kiely, SJ Lord, N Houssami, CY Lu, RL Ward, SA Pearson The Breast 38, 7-13, 2018 | 26 | 2018 |
| Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy AS Nelson, LJ Ashton, CM Vajdic, RE Le Marsney, B Daniels, ... Leukemia 29 (2), 441-447, 2015 | 25 | 2015 |
| Validity of algorithms for identifying five chronic conditions in MedicineInsight, an Australian national general practice database A Havard, JA Manski-Nankervis, J Thistlethwaite, B Daniels, R Myton, ... BMC Health Services Research 21 (1), 551, 2021 | 24 | 2021 |
| ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target D Liu, K Gunther, LA Enriquez, B Daniels, TA O’Mara, K Tang, AB Spurdle, ... Scientific Reports 10 (1), 13906, 2020 | 23 | 2020 |
| A national study on prescribed medicine use in Australia on a typical day CE Wylie, B Daniels, J Brett, SA Pearson, NA Buckley Pharmacoepidemiology and drug safety 29 (9), 1046-1053, 2020 | 21 | 2020 |
| Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort B Daniels, SJ Lord, BE Kiely, N Houssami, P Haywood, CY Lu, RL Ward, ... BMJ open 7 (1), e014439, 2017 | 21 | 2017 |
